Discrepancy between the effects of morronside on apoptosis in human embryonic lung fibroblast cells and lung cancer A549 cells. 2014

Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
Jiangsu Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China.

Morroniside is a water-soluble compound extracted from the fruit of Cornus officinalis and is used to protect lung activity against aging. In the present study, the manner in which morroniside regulates normal lung and cancer cells was examined. The human embryonic lung fibroblast (HELF) cell line and lung cancer A549 cell line, and their responses to morroniside treatment, were examined. Results showed that morroniside reverses the apoptotic effect of H2O2 on HELF cell growth, protecting cell proliferation and normal cell morphology and inhibiting apoptosis. However, these effects were not present in A549 cells. Western blotting showed that morroniside also markedly downregulated retinoblastoma protein in HELF cells. These results suggest that morroniside treatment exhibits different effects on apoptosis in HELF and A549 cells, making it a viable compound for decreasing the side effects of anticancer medicines in normal cells.

UI MeSH Term Description Entries

Related Publications

Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
April 2015, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
June 2018, Chinese journal of integrative medicine,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
April 2022, Oncology letters,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
September 2004, Experimental lung research,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
January 2016, Molecular medicine reports,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
September 2016, Molecular medicine reports,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
April 2018, Oncology letters,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
October 2015, Yao xue xue bao = Acta pharmaceutica Sinica,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
December 2019, Journal of pharmacopuncture,
Jian-Ping Chen, and DE-Guo Xu, and Xiao-Yi Yu, and Feng-Ming Zhao, and Dong-Qing Xu, and Xu Zhang, and Bao-Chang Cai, and Ming-Yan Wang
January 2017, Experimental lung research,
Copied contents to your clipboard!